Jorma Toppari
MD, PhD
jortop@utu.fi +358 29 450 2826 +358 40 180 2600 Kiinamyllynkatu 10 Turku Työhuone: C5 floor ORCID-tunniste: https://orcid.org/0000-0003-2228-334X |
Lastenendokrinologia; lisääntymisterveys; hormonaaliset haitta-aineet; kives; tyypin 1 diabetes
Professor Jorma Toppari (H-index 68) is an international expert in environmental endocrine disruption, male reproduction and type 1 diabetes. He is a principal investigator in a NIH-funded cohort study The Environmental Determinants of Diabetes in the Young (TEDDY) and in the Finnish Type 1 Diabetes Prediction and Prevention Study (DIPP). He is leading a joint Finnish-Danish birth cohort study exploring the genetic and environmental aspects of human reproduction.
The aim of our research is to identify risk factors of reproductive health and type 1 diabetes (T1D) to make risk management possible and prevent health problems. We are performing a comprehensive reproductive health study for 19-year-old men that we have followed up prospectively from pregnancy. We focus now our studies on sperm epigenome. We are studying the role of retinoblastoma protein (Rb) and E2F3 transcription factors in gonadal development and whether endocrine disruptors affect reproductive health. In the Finnish type 1 Diabetes Prediction and Prevention (DIPP) study and in The Environmental Determinants of Diabetes in the Young (TEDDY) study we are exploring the early determinants of T1D in large child cohorts with increased genetic risk.
Basic and clinical endocrinology, particularly pediatric and reproductive endocrinology, endocrine disruption, reproductive toxicology
- Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children (2022)
- Diabetes Care
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Maternal energy-adjusted fatty acid intake during pregnancy and the development of cows' milk allergy in the offspring (2022)
- British Journal of Nutrition
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Non-HLA Gene Polymorphisms in the Pathogenesis of Type 1 Diabetes: Phase and Endotype Specific Effects (2022)
- Frontiers in immunology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Novel Expression of Zona Pellucida 3 Protein in Normal Testis; Potential Functional Implications (2022)
- Molecular and Cellular Endocrinology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Onset and progression of puberty in Klinefelter syndrome (2022)
- Clinical Endocrinology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Permutation-based significance analysis reduces the type 1 error rate in bisulfite sequencing data analysis of human umbilical cord blood samples (2022)
- Epigenetics
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study (2022)
- Diabetes Care
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Prenatal exposure to phenols and benzophenones in relation to markers of male reproductive function in adulthood (2022)
- Frontiers in Endocrinology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories (2022)
- Nature Communications
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Reproductive Markers of Testicular Function and Size During Puberty in Boys With and Without a History of Cryptorchidism (2022)
- Journal of Clinical Endocrinology and Metabolism
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )



